193 related articles for article (PubMed ID: 32954467)
1. Association of tumor-infiltrating T lymphocytes with intestinal-type gastric cancer molecular subtypes and outcome.
Mansuri N; Birkman EM; Heuser VD; Lintunen M; Ålgars A; Sundström J; Ristamäki R; Lehtinen L; Carpén O
Virchows Arch; 2021 Apr; 478(4):707-717. PubMed ID: 32954467
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients.
Kawazoe A; Kuwata T; Kuboki Y; Shitara K; Nagatsuma AK; Aizawa M; Yoshino T; Doi T; Ohtsu A; Ochiai A
Gastric Cancer; 2017 May; 20(3):407-415. PubMed ID: 27629881
[TBL] [Abstract][Full Text] [Related]
3. Expression of Indoleamine 2, 3-dioxygenase 1 (IDO1) and Tryptophanyl-tRNA Synthetase (WARS) in Gastric Cancer Molecular Subtypes.
Lu S; Wang LJ; Lombardo K; Kwak Y; Kim WH; Resnick MB
Appl Immunohistochem Mol Morphol; 2020; 28(5):360-368. PubMed ID: 31033497
[TBL] [Abstract][Full Text] [Related]
4. Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas.
Choi E; Chang MS; Byeon SJ; Jin H; Jung KC; Kim H; Lee KL; Kim W; Park JH; Kim KH; Kim JS; Choi IS; Han DS; Ahn HS; Heo SC
Diagn Pathol; 2020 Jun; 15(1):69. PubMed ID: 32498695
[TBL] [Abstract][Full Text] [Related]
5. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
6. The Immune Microenvironment Impacts Survival in Western Patients with Gastric Adenocarcinoma.
Uppal A; Dehal A; Chang SC; Barrak D; Naeini Y; Jalas JR; Bilchik AJ
J Gastrointest Surg; 2020 Jan; 24(1):28-38. PubMed ID: 31625020
[TBL] [Abstract][Full Text] [Related]
7. Inflammation in gastric adenocarcinoma of the cardia: how do EBV infection, Her2 amplification and cancer progression influence tumor-infiltrating lymphocytes?
Haas M; Büttner M; Rau TT; Fietkau R; Grabenbauer GG; Distel LV
Virchows Arch; 2011 Apr; 458(4):403-11. PubMed ID: 21359545
[TBL] [Abstract][Full Text] [Related]
8. Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma.
Noble F; Mellows T; McCormick Matthews LH; Bateman AC; Harris S; Underwood TJ; Byrne JP; Bailey IS; Sharland DM; Kelly JJ; Primrose JN; Sahota SS; Bateman AR; Thomas GJ; Ottensmeier CH
Cancer Immunol Immunother; 2016 Jun; 65(6):651-62. PubMed ID: 27020682
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte-rich gastric cancer: associations with Epstein-Barr virus, microsatellite instability, histology, and survival.
Grogg KL; Lohse CM; Pankratz VS; Halling KC; Smyrk TC
Mod Pathol; 2003 Jul; 16(7):641-51. PubMed ID: 12861059
[TBL] [Abstract][Full Text] [Related]
10. Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response.
Shin SJ; Kim SY; Choi YY; Son T; Cheong JH; Hyung WJ; Noh SH; Park CG; Kim HI
Oncologist; 2019 Sep; 24(9):e835-e844. PubMed ID: 30894409
[TBL] [Abstract][Full Text] [Related]
11. Poor prognosis in Epstein-Barr virus-negative gastric cancer with lymphoid stroma is associated with immune phenotype.
Cho CJ; Kang HJ; Ryu YM; Park YS; Jeong HJ; Park YM; Lim H; Lee JH; Song HJ; Jung HY; Kim SY; Myung SJ
Gastric Cancer; 2018 Nov; 21(6):925-935. PubMed ID: 29627937
[TBL] [Abstract][Full Text] [Related]
12. CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8
Abe H; Saito R; Ichimura T; Iwasaki A; Yamazawa S; Shinozaki-Ushiku A; Morikawa T; Ushiku T; Yamashita H; Seto Y; Fukayama M
Virchows Arch; 2018 Apr; 472(4):643-651. PubMed ID: 29536167
[TBL] [Abstract][Full Text] [Related]
13. A study of the immune infiltrate and patient outcomes in esophageal cancer.
Conroy MJ; Kennedy SA; Doyle SL; Hayes B; Kavanagh M; van der Stok EP; O'Sullivan K; Cathcart MC; Reynolds JV; Lysaght J
Carcinogenesis; 2021 Apr; 42(3):395-404. PubMed ID: 32940666
[TBL] [Abstract][Full Text] [Related]
14. Expression of PD-L1, indoleamine 2,3-dioxygenase and the immune microenvironment in gastric adenocarcinoma.
Patil PA; Blakely AM; Lombardo KA; Machan JT; Miner TJ; Wang LJ; Marwaha AS; Matoso A
Histopathology; 2018 Jul; 73(1):124-136. PubMed ID: 29489025
[TBL] [Abstract][Full Text] [Related]
15. The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer.
Horn T; Laus J; Seitz AK; Maurer T; Schmid SC; Wolf P; Haller B; Winkler M; Retz M; Nawroth R; Gschwend JE; Kübler HR; Slotta-Huspenina J
World J Urol; 2016 Feb; 34(2):181-7. PubMed ID: 26055646
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral Immune Response to Gastric Cancer Varies by Molecular and Histologic Subtype.
Kim TS; da Silva E; Coit DG; Tang LH
Am J Surg Pathol; 2019 Jun; 43(6):851-860. PubMed ID: 30969179
[TBL] [Abstract][Full Text] [Related]
17. Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection.
Chiaravalli AM; Feltri M; Bertolini V; Bagnoli E; Furlan D; Cerutti R; Novario R; Capella C
Virchows Arch; 2006 Mar; 448(3):344-53. PubMed ID: 16261379
[TBL] [Abstract][Full Text] [Related]
18. Increased tumor-infiltrating CD8(+)Foxp3(+) T lymphocytes are associated with tumor progression in human gastric cancer.
Peng LS; Zhuang Y; Shi Y; Zhao YL; Wang TT; Chen N; Cheng P; Liu T; Liu XF; Zhang JY; Zuo QF; Mao XH; Guo G; Lu DS; Yu PW; Zou QM
Cancer Immunol Immunother; 2012 Nov; 61(11):2183-92. PubMed ID: 22729557
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Infiltrating Immune Cells Are Associated With Prognosis of Gastric Cancer.
Liu K; Yang K; Wu B; Chen H; Chen X; Chen X; Jiang L; Ye F; He D; Lu Z; Xue L; Zhang W; Li Q; Zhou Z; Mo X; Hu J
Medicine (Baltimore); 2015 Sep; 94(39):e1631. PubMed ID: 26426650
[TBL] [Abstract][Full Text] [Related]
20. The implication of tumor-infiltrating lymphocytes in Epstein-Barr virus-associated gastric carcinoma.
Gong LP; Chen JN; Xiao L; He Q; Feng ZY; Zhang ZG; Liu JP; Wei HB; Shao CK
Hum Pathol; 2019 Mar; 85():82-91. PubMed ID: 30448221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
